Xiangyu Medical Co. Ltd. A (688626) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Xiangyu Medical Co. Ltd. A (688626) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.05 Million ≈ $2.64 Million USD) by net assets (CN¥2.04 Billion ≈ $298.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Xiangyu Medical Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Xiangyu Medical Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688626 total liabilities for a breakdown of total debt and financial obligations.
Xiangyu Medical Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xiangyu Medical Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Saratoga Investama Sedaya
JK:SRTG
|
0.000x |
|
Shenzhen Changhong Tech
SHE:300151
|
0.045x |
|
Uniqure NV
NASDAQ:QURE
|
-0.072x |
|
HIAG Immobilien Holding AG
SW:HIAG
|
0.015x |
|
Wuxi Boton Technology Co Ltd
SHE:300031
|
0.008x |
|
Redwire Corp
NYSE:RDW
|
-0.022x |
|
Bank of Qingdao Co. Ltd
F:4BQ
|
0.192x |
|
Dogan Sirketler Grubu Holding AS
IS:DOHOL
|
0.116x |
Annual Cash Flow Conversion Efficiency for Xiangyu Medical Co. Ltd. A (2017–2024)
The table below shows the annual cash flow conversion efficiency of Xiangyu Medical Co. Ltd. A from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Xiangyu Medical Co. Ltd. A worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.05 Billion ≈ $300.68 Million |
CN¥178.59 Million ≈ $26.13 Million |
0.087x | -19.63% |
| 2023-12-31 | CN¥2.11 Billion ≈ $308.38 Million |
CN¥227.91 Million ≈ $33.35 Million |
0.108x | +12.36% |
| 2022-12-31 | CN¥1.94 Billion ≈ $283.86 Million |
CN¥186.70 Million ≈ $27.32 Million |
0.096x | +12.88% |
| 2021-12-31 | CN¥1.95 Billion ≈ $284.70 Million |
CN¥165.88 Million ≈ $24.27 Million |
0.085x | -70.72% |
| 2020-12-31 | CN¥743.29 Million ≈ $108.77 Million |
CN¥216.40 Million ≈ $31.67 Million |
0.291x | +2.18% |
| 2019-12-31 | CN¥547.28 Million ≈ $80.08 Million |
CN¥155.94 Million ≈ $22.82 Million |
0.285x | +59.30% |
| 2018-12-31 | CN¥414.81 Million ≈ $60.70 Million |
CN¥74.20 Million ≈ $10.86 Million |
0.179x | -70.12% |
| 2017-12-31 | CN¥99.09 Million ≈ $14.50 Million |
CN¥59.31 Million ≈ $8.68 Million |
0.599x | -- |
About Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment… Read more